dihexa cancer risk hgf c-met HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth – dihexa c-met cancer risk Developing
dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head HGF and MET: From Brain Development to Neurological Disorders PMC Downstream signalling and specific inhibition of c MET HGF pathway in small cell lung cancer: implications for tumour invasion British Journal of Cancer Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



